Safe Prescribing and Treatment Options for Opioid Dependency Symposium

The healthcare community in the Central Valley has seen an increase in problems arising from the use of pain management medications; therefore, the Central Valley Opioid Safety Coalition has developed a treatment symposium that will review safe prescribing guidelines for the central valley and treatment for those who are addicted to opioids.

Target Audience

This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including both the in-patient medical, surgical and out-patient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (Nurses, Pharmacists, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy, and are interested in treatment options.

Registration begins at 7:30 am and Symposium begins at 8 am

7:30 am – Registration

8 am - Safe Prescribing Guidelines - Michael Habibe, MD, Attending Emergency Physician at Saint Agnes Medical Center

8:30 am Screening Patients - How to Manage the Maze of Treatment Options - Bradley Wadja, DO

9:30 am The Role of a Pharmacist in Management of Opioid Addiction - Seth Gomez, PhamD

10:30 am Break/Vendors

11:00 am X-Waiver Doctor Speaks Out - Todd Fong, MD

11:30 am Medical Assisted Treatment (MAT) and Hub & Spoke Program - Todd Fong, MD & Jason Kletter

12:00 am Hub & Spoke Program - Michael Vang & Polina Gurvis

12:30 pm Lunch & Case Study Review

1:30 pm Case Study Discussion– Panel Speakers

5.0 CME

Breakfast and Lunch included

As a result of attending these live presentations, the participant will be able to:

-Identify opioid practice updates as outlined in the safe prescribing guideline for the Central Valley

-Increased knowledge for screening patients and treatment methods for patients with chronic opioid use

-Understand the comparative effectiveness of medications for addiction treatment (MAT)

-Address and review case studies for opioid use in women of childbearing age

-Improved understanding on becoming an opioid dependency treatment provide with approval to administer buprenorphine medications

-Identifying misuse and abuse, what the pharmacists’ contributions are to managing patient care

Accreditation Statement: The Fresno-Madera Medical Society (FMMS) is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

Credit Designation Statement: FMMS designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.